PitchBook News - Private fundraising's changing tastes

Chipmaker Arm files for long-awaited IPO; Q&A: Startup-to-startup M&A begins to simmer; healthcare specialist GPs defy fundraising slump
Read online | Don't want to receive these emails? Manage your subscription.
PitchBook
Log in
The Daily Pitch: VC
August 22, 2023
The Daily Pitch is powered by PitchBook’s industry-defining research and best-in-class data
Ads
In today's Daily Pitch, you'll find:
 
Today's Top Stories  
Global fundraising data shows LPs' shifting appetite
Private capital fundraising has been declining since Q4 2021, a trend that started accelerating at the end of last year, our latest Global Private Market Fundraising Report shows.

An arrested exit environment may be hindering LPs' ability to fund new investments from distributions of existing funds, but GPs are also easing demand for cash by ratcheting back on capital calls.

Despite the decline, allocators continue to make commitments because a down market has historically resulted in the best-performing funds. So far this year, private debt funds have made gains relative to other strategies, while VC and real assets have fallen from favor.
read the report
 
Share: Email LinkedIn Twitter Facebook
Decoding the blockbuster Arm IPO
SoftBank CEO Masayoshi Son has said Arm will benefit from the AI wave. (KAZUHIRO NOGI/Getty Images)
After months of speculation, SoftBank-backed chip designer Arm has filed to go public on the Nasdaq. Amid a volatile exit market, the listing stands to deliver SoftBank a long-awaited win.

SoftBank is the sole seller in the IPO and will remain in control of Arm after the offering. The IPO documents also revealed that Arm, whose chips are widely used in consumer devices, has yet to benefit from the AI frenzy.
read more
 
Share: Email LinkedIn Twitter Facebook
 
A message from McDermott Will & Emery  
Calling all trailblazers in healthcare, life sciences and private equity! The No. 1 conference series for healthcare dealmakers is heading to London on September 21.

Hosted by the leading law firm in healthcare private equity, HPE Europe 2023 is your golden ticket to make invaluable connections with the most influential industry leaders from across Europe including savvy investors, pharma and healthcare executives, and the best deal lawyers in the business.

Experience it firsthand to understand why previous attendees say, "McDermott conferences are amazing. They do the best job of getting the right people in the room and making connections."

Your next collaboration partner is waiting for you…so, what are you waiting for?

Register today using code HPEPITCHBOOK200 for £200 off registration.
Share: Email LinkedIn Twitter Facebook
 
B Capital's M&A adviser expects startup-to-startup M&A to heat up
Ronan Kennedy
(Chloe Ladwig/PitchBook News)
Acquisitions of VC-backed companies have been low, but Ronan Kennedy, who leads VC firm B Capital's internal M&A group, says that many startups are holding out until they have full-year financials for 2023 to kick off their sales processes.

Kennedy expects startup-to-startup M&A to take off as companies look to consolidate into larger platforms, but there are a couple of major roadblocks to these deals.
read more
 
Share: Email LinkedIn Twitter Facebook
Robust fundraising opportunities for healthcare specialist GPs
PE and VC healthcare specialist GPs are defying a difficult fundraising environment. From 2020 to 2021, PE healthcare specialist fundraising for North American and European managers increased 92.4%. Meanwhile, VC life-sciences fundraising increased 108.1%, and VC non-life-sciences healthcare fundraising rose 32.4%.

What's more, allocations for PE healthcare specialists and VC non-life-sciences healthcare specialists have remained elevated since 2021. By contrast, VC life-sciences managers' fundraising has normalized.

Historical outperformance by PE healthcare specialists may have contributed to fundraising success, while the track record of VC healthcare specialists has been mixed. Our Healthcare Funds Report compiles the H1 2023 fundraising status of 450 healthcare and life-sciences specialist managers by strategic style.
read the preview
 
Share: Email LinkedIn Twitter Facebook
Partly sunny skies for private investing in Q3
Mixed signals abound: Most indicators show the economy on firmer footing, but our model finds it's still likely the US will enter a recession by 2025. Venture capital funds produce some of the strongest quarterly returns, but their performance is also the most volatile, and the ecosystem is struggling with unfavorable exit conditions.

With 50-plus pages of charts, our Q3 2023 Quantitative Perspectives: US Market Insights peers into PE, VC, real estate, real assets and debt through a macroeconomic lens.
read it now
 
Share: Email LinkedIn Twitter Facebook
Recommended Reads
The search for winners in the new battery era. [Financial Times]

Venture capitalist Robert Nelsen has invested hundreds of millions in biotech company Altos Labs in hopes of rewriting the science of aging. [The Wall Street Journal]

Why fundraising challenges and higher interest rates have sent managers rushing to the business of net asset value loans. [Institutional Investor]
 
Since yesterday, the PitchBook Platform added:
9
VC valuations
2374
People
682
Companies
30
Funds
See what our data software can do
 
The Daily Benchmark:
2014 Vintage Global Real Estate Funds
Median IRR
11.24%
Top Quartile IRR
14.85%
1.06x
Median DPI
Select top performers
Exeter Industrial Value Fund III
L-A Saturn Acquisition
Realterm Logistics Fund I
*IRR: net of fees
65 Funds in Benchmark »
Check out the latest version of PitchBook Benchmarks
 
VC Deals  
Space technology startup Axiom Space has raised a $350 million Series C led by Aljazira Capital and Boryung, a South Korean healthcare company.

AI-powered clinical biotech company Genesis Therapeutics has raised a $200 million Series B co-led by an unnamed life sciences-focused investor and Andreessen Horowitz.

UK-based Enough has raised €40 million in a round led by World Fund and CPT Capital. The startup ferments fungi to produce protein for plant-based products.

Ghost, a B2B marketplace for surplus goods, has raised a $30 million Series B led by Cathay Innovation.

Qualifyze, a Frankfurt-based pharmaceutical supply chain compliance startup, has secured $12 million from investors including HV Capital, HarbourVest Partners and H14.

Zanifu, a Kenyan inventory financing platform, has closed an $11.2 million pre-Series A led by Beyond Capital Ventures and Variant Investments, TechCrunch reported.

FlashIntel, a SaaS sales company, has raised $10 million in seed funding, TechCrunch reported.

AI workflow automation startup Arkifi has raised over $9 million in seed funding led by Khosla Ventures and Nyca Partners.

UK-based property data and analytics startup Kamma has raised £3.6 million in a round led by Clean Growth Fund.

Lykon, a Berlin-based provider of personalized nutrition programs, has secured €2.5 million in a round led by Zintinus.
 
PitchBook webinar: Why allocators should rethink manager benchmarking
Allocators employing traditional, quartile-based benchmarking methodologies to screen private fund managers face challenges in capturing historical performance. These techniques not only fail to capture the range of performance within each quartile, but also fail to offer a simple way to aggregate performance across multiple funds within the same strategy and compare that performance against similar strategies.

In this webinar, analysts from our Quantitative Research team will discuss a new framework for analyzing manager performance and unpack its implications for the due diligence process.

Register now to secure your spot.
Share: Email LinkedIn Twitter Facebook
 
PE Deals  
The DeLuca and Buck families who own Subway are close to selling the chain of sandwich shops to Roark Capital for $9.8 billion, The Wall Street Journal reported. Other bidders include TDR Capital and Sycamore Partners.

US-listed materials and chemicals company DuPont is discussing the sale of its Delrin Resins division to The Jordan Company for around $1.8 billion, Bloomberg reported.

RRJ Capital has invested $300 million in Malaysia-based Yinson Holdings' offshore oil vessel called Agogo, which was acquired in February from Azule Energy for an estimated $5.3 billion.
 
Exit & IPOs  
Marsh has agreed to acquire Honan Insurance Group from TA Associates, which owns an 80% stake, and other investors. The Australian insurance company was last valued at around $449 million, Bloomberg reported.

Warburg Pincus has agreed to sell its more than 90% stake in Mumbai-based supply chain company Stellar Value Chain Solutions to France's Ceva Logistics.
 
Fundraising  
Blackstone Tactical Opportunities Fund IV has closed on $5.2 billion. Blackstone is expecting to secure several billion more in commitments to single-investor vehicles devoted to the strategy.

Allianz Global Investors is looking to raise at least €1.5 billion for a global private credit fund, Reuters reported.

Private credit fund Algoma Capital has launched with $100 million to lend to whiskey brands and distilleries.
 
Investors  
Sculptor Capital Management, which agreed in July to sell to Rithm Capital for about $639 million, has attracted a rival bid from a group of investors that includes Boaz Weinstein, William Ackman and Marc Lasry, all executives at other hedge funds, The Wall Street Journal reported.
 
Corporate M&A  
Permian Resources has agreed to acquire Earthstone Energy in a $4.5 billion all-stock deal. Both companies focus on exploration and production of oil and gas in the Permian Basin.
 
Chart of the Day  
"VC life sciences managers returned superior IRRs relative to the broader VC industry in two of three vintage buckets but posted considerably lower TVPIs across the board. This may be due to the capital-intensive nature of drug development. Meanwhile, VC healthcare specialists that do not focus on life sciences severely underperformed using IRR and moderately underperformed using TVPI. However, it is important to note that data counts for this analysis are low, particularly for the 'VC other healthcare' category."

Source: PitchBook's H1 2023 Healthcare Funds Report
 
About PitchBook | Terms of use | Advertise with us | Contact
Follow us: in twtr fb

This email was sent to you via the PitchBook Platform.

Do you want to change your email address, get a different edition or unsubscribe? Manage your subscription here.

© 2023 PitchBook. Win what's next. All rights reserved.

Older messages

VCs seek out stability in crypto sag

Monday, August 21, 2023

Football execs to debut VC fund; Europe's unicorn valuations break decadelong rise; Viome bags $86.5M Series C Read online | Don't want to receive these emails? Manage your subscription. Log in

China's investment malaise

Sunday, August 20, 2023

Plus: The end of the overcapitalization era, public BDCs suit up to catch lending wave, medtech's fair prognosis & more Read online | Don't want to receive these emails? Manage your

The overcapitalization of VC

Saturday, August 19, 2023

Also: Ranking the top VC & PE investors; Don't miss our webinar on how to improve the benchmarking experience; Get a sneak peek of our Crypto Report. Read online | Don't want to receive

VCs chase fresh medical tech

Friday, August 18, 2023

Telehealth startups turn to teen mental health; UK economy stars in 1st regional snapshot; Pivotal Commware picks up $102M Series D Read online | Don't want to receive these emails? Manage your

Ranking Q2's most active investors

Thursday, August 17, 2023

Infosec VCs hold on for M&A uptick; BitGo snags $100M Series C to develop crypto wallet; Lindus Health banks $18M Series A Read online | Don't want to receive these emails? Manage your

You Might Also Like

✅ ✅ SEO Black Friday came early this year...

Friday, November 15, 2024

The Google November Core Update 😨 ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

DOGA Rockets to the moon - a sign for web3 gaming?

Friday, November 15, 2024

PlayToEarn Newsletter #253 - Your weekly web3 gaming news ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Will this new tool disrupt search?

Friday, November 15, 2024

If you are wondering how Google, SearchGPT, and Bing compare and contrast, then I've got a great podcast episode for you today. Which new tool is positioned to disrupt search the most? Is it

Gensler’s Likely Exit as SEC Chair Sparks Legal Backlash

Friday, November 15, 2024

Plus Vaneck Predicts Bitcoin to Hit $180K by Summer 2024 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Move Over Temu: Amazon Launches Its Low-Cost Store [Crew Review]

Friday, November 15, 2024

Email is one of the easiest ways to grow your off-Amazon sales and support your on-Amazon sales. With Omnisend, setting up your campaigns couldn't be easier. Make email marketing easy. Hey Reader,

Weekly Dose of Optimism #120

Friday, November 15, 2024

Nuclear Plans, Nanotechnology, Evo, AlphaFold 3, Crowdsourced Networks, CRISPR Tomatoes ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Test Your IQ...🤔 To Crack The Interview

Friday, November 15, 2024

These guides will help you to test your IQ and even crack interviews Hello Reader, Just knowing the technical buzzwords in the thriving e-commerce industry may not be an ideal strategy to clear an e-

Supply chain tech looks to Japan

Friday, November 15, 2024

Healthcare IT is stuck in a VC rut; a tasty quarter for food deals; Databricks eyes $1B in fresh funding Read online | Don't want to receive these emails? Manage your subscription. Log in The Daily

Bluesky Thinking 🦋

Friday, November 15, 2024

Re: The X-odus. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Issue #42: AI Meets Media Magic

Friday, November 15, 2024

Issue #42: AI Meets Media Magic ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌